Centene Corporation Common Stock (CNC)
31.44
-1.08 (-3.32%)
NYSE · Last Trade: Jul 12th, 3:09 AM EDT
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Centene Corporation (“Centene”) (NYSE: CNC) on behalf of those who purchased or otherwise acquired Centene securities between December 12, 2024, and June 30, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is September 8, 2025.
By Kessler Topaz Meltzer & Check, LLP · Via Business Wire · July 11, 2025
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) securities between December 12, 2024 to June 30, 2025, inclusive (the “Class Period”). Centene investors have until September 8, 2025 to file a lead plaintiff motion.
By Glancy Prongay & Murray LLP · Via Business Wire · July 11, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · July 11, 2025
NEW YORK - July 11, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Centene Corporation (NYSE: CNC) of a class action securities lawsuit.
Via TheNewswire.com · July 11, 2025
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Centene To Contact Him Directly To Discuss Their Options
By Faruqi & Faruqi LLP · Via GlobeNewswire · July 11, 2025
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) securities between December 12, 2024 to June 30, 2025, inclusive (the “Class Period”). Centene investors have until September 8, 2025 to file a lead plaintiff motion.
By Law Offices of Howard G. Smith · Via Business Wire · July 10, 2025
Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Centene Corporation (NYSE: CNC) and certain of the Company’s senior executives for potential violations of the federal securities laws.
By Bleichmar Fonti & Auld LLP · Via Business Wire · July 10, 2025
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) between December 12, 2024 and June 30, 2025, inclusive.
By Bernstein Liebhard LLP · Via GlobeNewswire · July 10, 2025
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Centene Corporation (“Centene” or the “Company”) (NYSE: CNC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · July 10, 2025
The law firm of Robbins Geller Rudman & Dowd LLP announces that the Centene class action lawsuit seeks to represent purchasers or acquirers of Centene Corporation (NYSE: CNC) securities between December 12, 2024 and June 30, 2025, inclusive (the “Class Period”). Captioned Lunstrum v. Centene Corporation, No. 25-cv-05659 (S.D.N.Y.), the Centene class action lawsuit charges Centene and certain of Centene’s top executives with violations of the Securities Exchange Act of 1934.
By Robbins Geller Rudman & Dowd LLP · Via Business Wire · July 10, 2025
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Centene Corporation (“Centene” or “the Company”) (NYSE: CNC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By The Schall Law Firm · Via Business Wire · July 9, 2025
NEW YORK, July 09, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Centene Corporation (“Centene” or the “Company”) (NYSE:CNC) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired Centene securities between December 12, 2024 to June 30, 2025, both dates inclusive (the “Class Period”). Investors have until September 8, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
By Bragar Eagel & Squire · Via GlobeNewswire · July 9, 2025
SAN DIEGO, July 09, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · July 9, 2025
NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Centene Corporation (“Centene” or the “Company”) (NYSE:CNC) on behalf of Centene stockholders. Our investigation concerns whether Centene has violated the federal securities laws and/or engaged in other unlawful business practices.
By Bragar Eagel & Squire · Via GlobeNewswire · July 7, 2025
NEW YORK, July 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Centene Corporation (“Centene” or the “Company”) (NYSE: CNC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · July 6, 2025
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) investors concerning the Company’s possible violations of the federal securities laws.
By Glancy Prongay & Murray LLP · Via Business Wire · July 3, 2025
Law Offices of Howard G. Smith announces an investigation on behalf of Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) investors concerning the Company’s possible violations of federal securities laws.
By Law Offices of Howard G. Smith · Via Business Wire · July 2, 2025
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Centene Corporation (“Centene” or “the Company”) (NYSE: CNC) for violations of the securities laws.
By The Schall Law Firm · Via Business Wire · July 2, 2025
The Law Offices of Frank R. Cruz announces an investigation of Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) on behalf of investors concerning the Company’s possible violations of federal securities laws.
By The Law Offices of Frank R. Cruz · Via Business Wire · July 2, 2025
The DJS Law Group announces that it is investigating claims on behalf of investors of Centene Corporation (“Centene” or “the Company”) (NYSE: CNC) for violations of the securities laws.
By DJS Law Group · Via Business Wire · July 2, 2025

Duo Health (“Duo”), a new type of value-based medical group purpose-built to manage chronic kidney disease (CKD) and end-stage kidney disease (ESKD), announced today it has entered into a strategic partnership with Arizona Complete Health, a company that provides and administers health benefits through individual, Medicaid, Medicare and dual-eligible programs and a Centene Corporation company (NYSE: CNC). This partnership builds on Arizona Complete Health’s existing value-based care nephrology network arrangements and is designed to enhance patient engagement and improve outcomes for Medicare members with CKD and ESKD.
By Duo Health · Via Business Wire · July 16, 2024

Managed care health insurance company Centene Inc. (NYSE: CNC) recently saw its share rebound after reaffirming its guidance. This move came
Via MarketBeat · June 4, 2024

UnitedHealth Group has, to date, been unaffected by the rising costs of Medicare Advantage; investors must decide if that shoe is yet to drop
Via MarketBeat · February 19, 2024

Humana and Cigna are exploring a merger, aiming to conclude the deal before year-end, creating a healthcare giant with a potential market value of $137 billion.
Via MarketBeat · December 2, 2023

During the peak of the recent selloff, the healthcare sector outshone, with three stocks showing resilience and impressive upward moves.
Via MarketBeat · October 12, 2023